ArticleJCO oncology practice2022

Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A.

Rachel A Freedman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.